Optical Coherence Tomography of the Retina in Multiple Sclerosis


Neuroaxonal loss is a key factor in the pathophysiology of multiple sclerosis (MS), closely linked to clinical disability. However, monitoring neuroaxonal loss directly in vivo remains difficult.

Optical coherence tomography (OCT) provides a non-invasive and patient-friendly method to visualize and measure the layers of neurons and axons in the retina, with high consistency in results across different raters and repeat assessments. OCT changes are commonly observed in patients with MS (PwMS), resulting from clinically apparent or subclinical optic nerve demyelination, retrograde degeneration due to damage in the posterior visual pathway, and primary degeneration of ganglion cells, which occurs alongside neuronal degeneration in other parts of the central nervous system.


Selected scientific publications

From: Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis

Background
Retinal degeneration leading to optical coherence tomography (OCT) changes is frequent in patients with multiple sclerosis (PwMS).


Objective
To investigate associations among OCT changes, MRI measurements of global and regional brain volume loss, and physical and cognitive impairment in PwMS. read

Cortex_OCT

Associations of regional cortical volumes with OCT measures and with measures of disability. The effect size, expressed as standardized beta (β), is graphically displayed for each of the Desikan-Killiany atlas regions presenting significant association after multiple comparisons correction. Abbreviations: pRNFL peripapillary retinal nerve fiber layer; GCIPL ganglion cell-inner plexiform layer; INL inner nuclear layer; EDSS, Expanded Disability Status Scale; SDMT Symbol Digit Modalities Test; β standardized regression coefficient

From: Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway.

Assessment of the lateral geniculate nucleus (LGN) and the other nodes of the visual pathway. The LGN is the central node of the visual pathway, receiving input from retinal ganglion cells and sending axons to the primary visual cortex. To study structural damage and its relation to anterograde and retrograde degeneration, several visual pathway nodes were assessed. (A) Retinal ganglion cell integrity was evaluated using optical coherence tomography (OCT), with the mean ganglion cell-inner plexiform layer (GC-IPL) thickness measured. (B) LGN volume was measured using 3D MPRAGE T1-weighted MRI and the MAGeT Brain algorithm, with the LGN segmented in red and the medial geniculate nucleus in green as a control. (C, D) Damage to the optic radiations (OR) was assessed with diffusion-weighted MRI, including the mean fractional anisotropy (FA) and OR lesion volume. The schematic figure of the afferent visual system (on the left) is adapted from the website of the Neurodiagnostics Laboratory @ Charité-Universitätsmedizin Berlin, Germany (neurodial.de/2017/08/25/schematic-figure-the-afferent-visual-system-creative-commons-license). read

OCT

From Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis.

Correlations between OCT measures of neuroaxonal loss and measures of disability. Scatter plots showing the correlation analysis between OCT (pRNFL and GCIPL: mean of both eyes, with exclusion of ON-eyes) and disability measures (SDMT and EDSS). (a) Correlation between GCIPL volume and SDMT. (b) Correlation between pRNFL thickness and SDMT. (c) Correlation between GCIPL volume and EDSS (log10). (d) Correlation between pRNFL thickness and EDSS (log10). read

OCT

Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway.
Papadopoulou A, Gaetano L, Pfister A, Altermatt A, Tsagkas C, Morency F, Brandt AU, Hardmeier M, Chakravarty MM, Descoteaux M, Kappos L, Sprenger T, Magon S.
Neurology. 2019 May 7;92(19):e2240-e2249. doi: 10.1212/WNL.0000000000007450. Epub 2019 Apr 10. PMID: 30971483; PMCID: PMC6537126. read

Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis.
Cerdá-Fuertes N, Stoessel M, Mickeliunas G, Pless S, Cagol A, Barakovic M, Maceski AM, Álvarez González C, D' Souza M, Schaedlin S, Benkert P, Calabrese P, Gugleta K, Derfuss T, Sprenger T, Granziera C, Naegelin Y, Kappos L, Kuhle J, Papadopoulou A.
Mult Scler. 2023 Nov;29(13):1540-1550. doi: 10.1177/13524585231198760. Epub 2023 Sep 29. PMID: 37772490; PMCID: PMC10637109. read

Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.
Cagol A, Fuertes NC, Stoessel M, Barakovic M, Schaedelin S, D'Souza M, Würfel J, Brandt AU, Kappos L, Sprenger T, Naegelin Y, Kuhle J, Granziera C, Papadopoulou A.
J Neurol. 2023 Apr;270(4):2139-2148. doi: 10.1007/s00415-022-11535-8. Epub 2023 Jan 10. PMID: 36625888; PMCID: PMC10025239. read